A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients

Acta Oncologica

Volumn 50, Issue 6, 2011, Pages 883-888

  Møller, Ditte Sloth ^a   Khalil, Azza Ahmed ^a   Knap, Marianne Marquard ^a   Muren, Ludvig Paul ^a   Hoffmann, Lone ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; NAVELBINE;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ESOPHAGUS; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; VINBLASTINE;

EID: 79960510962     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.581694     Document Type: Conference Paper

References (25)

1. Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi AT, et al. Estimation of tumor con-trol probability model parameters from 3-D dose distribu-tions of non-small cell lung cancer patients. Lung Cancer 1999;24:31-7. (Pubitemid 29241815)
2. Mehta M, Manon R. Are more aggressive therapies able to improve treatment of locally advanced non-small cell lung cancer: Combined modality treatment? Semin Oncol 2005;32:S25-34.
3. Kong FM, Haken RKT, Schipper MJ, Sullivan MA, Chen M, Lopez C, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unre-sectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:324-33. (Pubitemid 41317147)
4. Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23-33. (Pubitemid 32041273)
5. Fenwick JD, Nahum AE, Malik ZI, Eswar CV, Hatton MQ, Laurence VM, et al. Escalation and intensifi cation of radio-therapy for stage III non-small cell lung cancer: Opportuni-ties for treatment improvement. Clin Oncol 2009;21: 343-60.
6. Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 2004;73: 285-7. (Pubitemid 39601075)
7. Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon Jv, Houben R, et al. Identifi cation of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 2009;91:386-92.
8. Manus MPM, Hicks RJ, Matthews JP, Wirth A, Rischin D, Ball DL. Metabolic (FDG-PET) response after radical radi-otherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 2005;49: 95-108. (Pubitemid 40798098)
9. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61:318-28. (Pubitemid 40164423)
10. Van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans A-MC, et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J Clin Oncol 2010;28:1380-6.
11. St-Hilaire J, S é vigny C, Beaulieu F, Germain F, Lavoie C, Dagnault A, et al. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients. Radiother Oncol 2009;91:342-8.
12. Tanoue LT, Detterbeck FC. New TNM classifi cation for non-small-cell lung cancer. Expert Rev Anticancer Ther 2009;9:413-23.
13. Wolthaus JWH, Schneider C, Sonke J-J, van Herk M, Bel-derbos JSA, Rossi MMG, et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys 2006;65:1560-71. (Pubitemid 44425229)
14. Prescribing, recording, and reporting intensity-modulated photon-beam therapy. J ICRU 2010 Report No. 83;10.
15. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzen-rider JE, et al. Tolerance of normal tissue to therapeutic irra-diation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
16. Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76:S70-6.
17. Adkison JB, Khuntia D, Bentzen SM, Cannon GM, Tome WA, Jaradat H, et al. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratifi ed phase I dose escalation study. Technol Cancer Res Treat 2008;7:441-7.
18. Koukourakis M, Hlouverakis G, Kosma L, Skarlatos J, Dami-lakis J, Giatromanolaki A, et al. The impact of overall treatment time on the results of radiotherapy for non small cell lung carcinoma. Int J Radiat Oncol Biol Phys 1996;34:315-22. (Pubitemid 26031576)
19. Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients. Acta Oncol 2010;49:1077-84.
20. MacManus M, Nestle U, Rosenzweig KE, Carrio I, Messa C, Belohlavek O, et al. Use of PET and PET/CT for radia-tion therapy planning: IAEA expert report 2006-2007. Radi-other Oncol 2009;91:85-94.
21. Aerts HJWL, Bosmans G, van Baardwijk AAW, Dekker ALAJ, Oellers MC, Lambin P, et al. Stability of 18F-deoxy-glucose uptake locations within tumor during radiotherapy for NSCLC: A prospective study: Int J Radiat Oncol Biol Phys 2008;71:1402-7.
22. Sura S, Greco C, Gelblum D, Yorke ED, Jackson A, Rosen-zweig KE. (18)F-fl uorodeoxyglucose positron emission tom-ography-based assessment of local failure patterns in non-small-cell lung cancer treated with defi nitive radiother-apy. Int J Radiat Oncol Biol Phys 2008;70:1397-402. (Pubitemid 351417758)
23. Aerts HJWL, Lambin P, Ruysscher DD. FDG for dose paint-ing: A rational choice. Radiother Oncol 2010;97:163-4.
24. Partridge M, Yamamoto T, Grau C, H ø yer M, Muren LP. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol 2010;49:997-1011.
25. Nyeng TB, Kallehauge JF, H ø yer M, Petersen JBB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol (in press).